SMAD3 and Insulin resistance: These Smad3-deficient db/db mice (Smad3KO-db/db) demonstrate β cell hyperplasia, persistent hyperinsulinemia, normal glycemia, recovered glucose tolerance, and eliminated insulin resistance [37].